Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: J Am Acad Child Adolesc Psychiatry. 2015 Apr 27;54(7):550–556. doi: 10.1016/j.jaac.2015.04.004

Table 1.

Preschool Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment Study (PATS) Medication Follow-Up: Sample Characteristics at Years 3 and 6

Year 3 (n=206) Year 6 (n=179)
Age, mean (SD) 7.4 (0.97) 10.4 (0.99)
Gender, n (%)
  Male 154 (74.8) 133 (74.3)
  Female 52 (25.2) 46 (25.7)
Ethnicity, n (%)
  Hispanic or Latino 40 (19.4) 30 (16.8)
  Non-Hispanic or -Latino 166 80.6 149 (83.2)
Race,a n (%)
  White 159 (77.2) 134 (74.9)
  Black or African American 44 (21.4) 37 (20.7)
  American Indian/Alaskan Native 14 (6.8) 14 (7.8)
  Asian 3 (1.5) 5 (2.8)
  Native Hawaiian/Pacific Islander 2 (1.0) 0 (0)
  Other 17 (8.3) 17 (9.5)
Public assistance, n (%) 23 (11.2) 10 (5.6)
Parent(s) with college or higher degree,b n (%) 141 (69.5) 132 (75.4)
Family composition, n (%)
  2 parental figures 159 (77.2) 134 (74.9)
  1 parental figure 45 (21.8) 41 (22.9)
  N/A -missing 2 (1.0) 4 (2.2)
C-GAS, c mean (SD) 53.7 (10.1) 56.5 (10.07)
Comorbidity,d n(%)
  ODD/CD
85 (41.7) 60 (33.7)
  Anxiety disordere 31 (15.2) 37 (20.1)
  Mood disorder 18 (8.8) 15 (8.4)
  PDD 12 (5.9) 16 (6.0)
  Psychotic disorder 1 (0.5) 2 (1.1)

Note: CD = conduct disorder; CGAS = Children’s Global Assessment Scale; ODD = oppositional defiant disorder; PDD = pervasive developmental disorder.

a

Some participants endorsed more than one race

b

Three missing at year 3 and 4 at year 6

c

2 missing at year 3 and 1 at year 6

d

Comorbidity data were missing for 2 children at year 3 and 1 child at year 6

e

Excluding specific phobia